Ma B - Search Results

1

Transcriptomics of Epstein-Barr virus aids to the classification of T-cell evasion in nasopharyngeal carcinoma.

Mahajan S, Bongaerts M, Hardillo J, Tsang A, Lo KW, Kortleve D, Ma B, Debets R. Mahajan S, et al. Among authors: ma b. Curr Opin Immunol. 2023 Aug;83:102335. doi: 10.1016/j.coi.2023.102335. Epub 2023 May 24. Curr Opin Immunol. 2023. PMID: 37235920 Free article. Review.

2

Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response.

Ma BB, Lui VW, Poon FF, Wong SC, To KF, Wong E, Chen H, Lo KW, Tao Q, Chan AT, Ng MH, Cheng SH. Ma BB, et al. Invest New Drugs. 2010 Jun;28(3):326-33. doi: 10.1007/s10637-009-9316-7. Epub 2009 Sep 16. Invest New Drugs. 2010. PMID: 19756373 Free PMC article.

3

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079).

Ma BB, Goh BC, Lim WT, Hui EP, Tan EH, Lopes Gde L, Lo KW, Li L, Loong H, Foster NR, Erlichman C, King AD, Kam MK, Leung SF, Chan KC, Chan AT. Ma BB, et al. Invest New Drugs. 2015 Aug;33(4):985-91. doi: 10.1007/s10637-015-0264-0. Epub 2015 Jun 19. Invest New Drugs. 2015. PMID: 26084990 Clinical Trial.

4

The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinoma.

Hui EP, Ma BBY, Chan ATC. Hui EP, et al. Among authors: ma bby. Curr Opin Oncol. 2020 May;32(3):187-195. doi: 10.1097/CCO.0000000000000622. Curr Opin Oncol. 2020. PMID: 32175925 Review.

5

Targeting the polycomb repressive complex-2 related proteins with novel combinational strategies for nasopharyngeal carcinoma.

Zhu J, Li L, Tong J, Hui C, Wong CH, Lo KW, Chan R, Ai QY, Hui EP, Chan AT, To KF, Tao Q, Ma BB. Zhu J, et al. Am J Cancer Res. 2020 Oct 1;10(10):3267-3284. eCollection 2020. Am J Cancer Res. 2020. PMID: 33163269 Free PMC article.

6

MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.

Wang Y, Chen H, Liu W, Yan H, Zhang Y, Cheung AHK, Zhang J, Chen B, Liang L, Zhou Z, Wong CC, Wu WKK, Chan MWY, Cheng ASL, Ma BBY, Yu J, Lo KW, To KF, Kang W. Wang Y, et al. Among authors: ma bby. Theranostics. 2022 Sep 6;12(15):6509-6526. doi: 10.7150/thno.75431. eCollection 2022. Theranostics. 2022. PMID: 36185598 Free PMC article.

7

Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.

Zhang J, Chen B, Li H, Wang Y, Liu X, Wong KY, Chan WN, Chan AK, Cheung AH, Leung KT, Dong Y, Pan Y, Ke H, Liang L, Zhou Z, Xiao J, Wong CC, Wu WK, Cheng AS, Ma BB, Yu J, Lo KW, Kang W; Ka Fai To. Zhang J, et al. Among authors: ma bb. J Pathol. 2023 Feb;259(2):205-219. doi: 10.1002/path.6033. Epub 2022 Dec 17. J Pathol. 2023. PMID: 36373776

8

Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon Radiotherapy.

Mahajan S, Balcioglu HE, Oostvogels A, Dik WA, Chan KCA, Lo KW, Hui EP, Tsang A, Tong J, Lam WKJ, Wong K, Chan ATC, Ma BBY, Debets R. Mahajan S, et al. Among authors: ma bby. Cancers (Basel). 2023 Mar 21;15(6):1887. doi: 10.3390/cancers15061887. Cancers (Basel). 2023. PMID: 36980772 Free PMC article.

9

Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models.

Lam RCT, Hui CWC, Wong CH, Lo KW, Tsang ACM, Hui EP, Chan ATC, Ma BBY. Lam RCT, et al. Among authors: ma bby. Invest New Drugs. 2023 Oct;41(5):699-709. doi: 10.1007/s10637-023-01384-1. Epub 2023 Aug 12. Invest New Drugs. 2023. PMID: 37572231

10

Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal Cancer.

Chan KCA, Lam WKJ, King A, Lin VS, Lee PPH, Zee BCY, Chan SL, Tse IOL, Tsang AFC, Li MZJ, Jiang P, Ai QYH, Poon DMC, Au KH, Hui EP, Ma BBY, Van Hasselt AC, Chan ATC, Woo JKS, Lo YMD. Chan KCA, et al. Among authors: ma bby. NEJM Evid. 2023 Jul;2(7):EVIDoa2200309. doi: 10.1056/EVIDoa2200309. Epub 2023 Jun 27. NEJM Evid. 2023. PMID: 38320164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,129 results

Search Page